Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02958735
Other study ID # IRB00076336
Secondary ID
Status Completed
Phase N/A
First received October 31, 2016
Last updated August 15, 2017
Start date August 1, 2016
Est. completion date May 2, 2017

Study information

Verified date August 2017
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether an acute bout of exercise may temporarily enhance cognitive function (such as memory or attention span) by measuring behavioral performance on cognitive tests, as well as expression of hormones in circulation associated with brain plasticity and stress.


Description:

This is a randomized experiment consisting of three visits for each participant. Participants are determined to be eligible beforehand during a phone screening, in which the various study inclusions and exclusions are determined and the Physical Activity Readiness Questionnaire for Everyone 2015 (PARQ) is administered.

In the first visit, various anthropometric data are collected from participants, such as height, weight, and waist and hip circumference. The participants' blood pressure is also checked for hypertension. The participants are given Dual Energy X-Ray Absorptiometry (DEXA) scans to determine total body composition (bone, fat, and fat-free mass) If the participant is female, a urine analysis to determine pregnancy is required during the visit before the DEXA to ensure safety. Participants are given the Rapid Assessment of Physical Activity (RAPA) questionnaire to assess habitual activity levels. The participants' muscle strength is also measured using the Biodex System 3, an isokinetic dynamometer. The participants then undergo a maximal stress test on a treadmill integrated with a Cardinal Health Metabolic/ECG cart using a modified Balke protocol, beginning at 3 mph, 0% grade, and increasing 2.5% grade every 3 minutes. The ECG component of the metabolic cart will be used for continuous heart rate monitoring as part of the fitness assessment. Cardiorespiratory parameters (VO2, ventilation, respiratory rate) will also be measured throughout the test. Blood pressure is measured during the last 30 seconds of each exercise stage and the rating of perceived exertion (RPE) using the Borg 6 to 20 scale is obtained during each stage. Subjects are urged to give a maximal effort and are pushed until volitional fatigue.

In the second visit, participants are first given a series of cognitive tests designed to quantify such cognitive faculties as visual short-term memory, selective attention, processing speed, and verbal fluency. These tests consist of seeing simple images on a computer screen, such as a series of colored shapes, and responding using a keypad. A blood sample is also collected from the participants to serve as a baseline. The subject is then randomized to one of three groups: the first group rests for 30 minutes; the second group walks on the treadmill at a mild intensity, defined as maintaining 60% of the heart rate observed during the max VO2 from the first visit; the last group walks on the treadmill at a hard intensity, defined as maintaining 80% of the heart rate observed during the max VO2 from the first visit. The subjects then undergo a second blood draw after cooling down, followed immediately by another round of the same cognitive tests. An hour after finishing the exercise intervention, the same procedure of blood draw followed by cognitive tests is repeated, and an hour after that it is repeated again.

The third visit must be about 24 hours after the previous visit. Participants have blood drawn and one final round of cognitive tests.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 2, 2017
Est. primary completion date May 2, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Body mass index (BMI) of between 18.5 and 35 kg/m2

- Normal or corrected-to-normal vision

- No contraindications to participation in moderate to hard intensity physical activity

Exclusion Criteria:

- Self-report of alcohol or substance abuse in the past year or current treatment

- Women who are pregnant or nursing

- BMI of < 18.5 or > 35 kg/m2

- Diabetes mellitus. Subjects will be excluded for diabetes even if controlled by medications

- Cigarette smoking in the previous 12 weeks

- Elevated blood pressure (BP) defined as systolic BP = 140 mm Hg or diastolic BP = 90 mm Hg

- Self-report of cardiovascular disease, cancer, renal disease, and other serious conditions that could be exacerbated by moderate intensity physical activity.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise Challenge
Participants randomized to an exercise condition will perform treadmill exercise for 30 minutes. Participants will self-select a comfortable walking speed. The treadmill grade will be adjusted to elicit and maintain the target heart rate.

Locations

Country Name City State
United States Johns Hopkins Bayview Medical Center Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary visual short-term memory questionnaire participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%) baseline
Primary visual short-term memory questionnaire participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%) up to 5 minutes post intervention
Primary visual short-term memory questionnaire participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%) 1 hour after intervention
Primary visual short-term memory questionnaire participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%) 2 hours after intervention
Primary visual short-term memory questionnaire participants are shown sets of colored squares briefly and must pick out the square that changed color after a delay, scored on accuracy (0-100%) 24 hours after baseline
Primary visual long-term memory questionnaire participants encode images in a cover task at baseline, scored on accuracy (0-100%) 24 hours after baseline
Primary verbal fluency participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words baseline
Primary verbal fluency participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words up to 5 minutes post intervention
Primary verbal fluency participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words 1 hour after intervention
Primary verbal fluency participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words 2 hours after intervention
Primary verbal fluency participants are asked to name as many words as they can that begin with a certain letter within 1 minute, scored on number of appropriate words 24 hours after baseline
Primary cortisol in circulation in nanograms per milliliter (ng/ml) baseline
Primary cortisol in circulation in nanograms per milliliter (ng/ml) up to 5 minutes post intervention
Primary cortisol in circulation in nanograms per milliliter (ng/ml) 1 hour after intervention
Primary cortisol in circulation in nanograms per milliliter (ng/ml) 2 hours after intervention
Primary cortisol in circulation in nanograms per milliliter (ng/ml) 24 hours after baseline
Primary igf-1 in circulation insulin-like growth factor 1 in nanograms per milliliter (ng/ml) baseline
Primary igf-1 in circulation insulin-like growth factor 1 in nanograms per milliliter (ng/ml) up to 5 minutes post intervention
Primary igf-1 in circulation insulin-like growth factor 1 in nanograms per milliliter (ng/ml) 1 hour after intervention
Primary igf-1 in circulation insulin-like growth factor 1 in nanograms per milliliter (ng/ml) 2 hours after intervention
Primary igf-1 in circulation insulin-like growth factor 1 in nanograms per milliliter (ng/ml) 24 hours after baseline
Primary bdnf in circulation brain-derived neurotrophic factor in nanograms per milliliter (ng/ml) baseline
Primary bdnf in circulation brain-derived neurotrophic factor in nanograms per milliliter (ng/ml) up to 5 minutes post intervention
Primary bdnf in circulation brain derived neurotrophic factor in nanograms per milliliter (ng/ml) 1 hour after intervention
Primary bdnf in circulation brain-derived neurotrophic factor in nanograms per milliliter (ng/ml) 2 hours after intervention
Primary bdnf in circulation brain-derived neurotrophic factor in nanograms per milliliter (ng/ml) 24 hours after baseline
Primary general executive functioning as assessed by the stroop test questionnaire participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds baseline
Primary general executive functioning as assessed by the stroop test questionnaire participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds up to 5 minutes post intervention
Primary general executive functioning as assessed by the stroop test questionnaire participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds 1 hour after intervention
Primary general executive functioning as assessed by the stroop test questionnaire participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds 2 hours after intervention
Primary general executive functioning as assessed by the stroop test questionnaire participants must identify the color of various words on the screen irrespective of their meaning, scored based on accuracy (0-100%) and reaction time in milliseconds 24 hours after baseline
Primary general executive functioning as assessed by the flanker task questionnaire participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds baseline
Primary general executive functioning as assessed by the flanker task questionnaire participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds up to 5 minutes post intervention
Primary general executive functioning as assessed by the flanker task questionnaire participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds 1 hour after intervention
Primary general executive functioning as assessed by the flanker task questionnaire participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds 2 hours after intervention
Primary general executive functioning as assessed by the flanker task questionnaire participants must identify the orientation of a central arrow while ignoring those of other arrows on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds 24 hours after baseline
Primary general executive functioning as assessed by the irrelevant capture task questionnaire participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds baseline
Primary general executive functioning as assessed by the irrelevant capture task questionnaire participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds up to 5 minutes post intervention
Primary general executive functioning as assessed by the irrelevant capture task questionnaire participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds 1 hour after intervention
Primary general executive functioning as assessed by the irrelevant capture task questionnaire participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds 2 hours after intervention
Primary general executive functioning as assessed by the irrelevant capture task questionnaire participants must identify a set of symbols as either letters or numbers while ignoring distracting images that flash on the screen, scored based on accuracy (0-100%) and reaction time in milliseconds 24 hours after baseline
Secondary total and regional bone mass as assessed by dual-energy x-ray absorptiometry (DEXA) scan, in grams per square centimeter (g/cm2) baseline
Secondary total and regional fat and fat-free mass as assessed by dual-energy x-ray absorptiometry (DEXA) scan in grams per square centimeter (g/cm2) baseline
Secondary habitual activity levels as assessed by Rapid Assessment of Physical Activity questionnaire, possible scores are: Active, Under Active Regular, Under Active Regular- Light Activities, Under Active, Sedentary baseline
Secondary muscle strength as measured by isokinetic testing using the Biodex System 3 baseline
Secondary cardiorespiratory endurance as assessed by maximal stress test, represented by heart rate at maximal oxygen uptake baseline
Secondary body mass index (BMI) measured in kilograms per square meter (kg/m2) baseline
Secondary waist-to-hip ratio baseline
See also
  Status Clinical Trial Phase
Completed NCT01711008 - The Effect of Breakfast Size Prior to Morning Exercise on Cognition, Mood and Appetite in Habitually Active Women N/A
Not yet recruiting NCT05468684 - PROCO Neck: The Course and Neuroplasticity in Neck Pain-Associated Disorders and Whiplash-Associated Disorders
Recruiting NCT02891343 - Effect of Hypoxia on Cognitive Assessment and Cerebral Activity in Healthy Volunteers N/A
Completed NCT02486328 - The Effect of Different Sedation Regimes on Cognitive Function in Lower Gastrointestinal System Endoscopy Phase 4
Active, not recruiting NCT01877967 - Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults N/A
Completed NCT01429103 - Hormones and Cognition in the Menopausal Transition N/A
Completed NCT02300272 - Health Behaviors and Time-of-Day: Older Adult Cognitive Function
Completed NCT02270320 - Cognitive Effects of Tai Chi Chuan in Healthy Older Adults and Older Adults N/A
Completed NCT01012947 - Cognitive Health Promotion Project in the Community Phase 1
Recruiting NCT02792985 - Multisensory Stimulation and Enriched Environments During Post-traumatic Amnesia N/A
Completed NCT01555996 - Early Occupational Therapy for Delirium Prevention in Older Patients Admitted to Critical Care Unit N/A
Completed NCT02884050 - Physiologic Effects of Topiramate on Cognition Phase 1
Completed NCT02847793 - Attentional Bias Modification Through Eye-tracker Methodology (ABMET) N/A